Thus, some modern synthetic peptides-based therapeutics that mimic SMAC and HtrA2 trigger apoptosis or sensitize tumor cell lines to apoptosis induced by cytotoxic anticancer drugs or TRAIL in vitro and even in some tumor xenograft models [52]. The gene discussed is HTRA2; the disease is neoplasm.